Tom J. Parry

1.4k total citations
41 papers, 1.1k citations indexed

About

Tom J. Parry is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Neurology. According to data from OpenAlex, Tom J. Parry has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 8 papers in Neurology. Recurrent topics in Tom J. Parry's work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Multiple Sclerosis Research Studies (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Tom J. Parry is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Multiple Sclerosis Research Studies (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Tom J. Parry collaborates with scholars based in United States, United Kingdom and Germany. Tom J. Parry's co-authors include James G. McElligott, Anthony O. Caggiano, Carol Poortman, Les Sekut, John J. Siekierka, Dennis Argentieri, Robert Falotico, Bruce P. Damiano, Jennifer F. Iaci and Bonnie Sturm and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Tom J. Parry

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom J. Parry United States 17 386 225 212 143 125 41 1.1k
Rebecca Lever United Kingdom 15 330 0.9× 74 0.3× 181 0.9× 154 1.1× 143 1.1× 18 1.2k
Ignacio M. Larráyoz Spain 23 645 1.7× 87 0.4× 263 1.2× 155 1.1× 98 0.8× 72 1.6k
Jaap Rip Netherlands 20 585 1.5× 296 1.3× 180 0.8× 60 0.4× 215 1.7× 42 1.4k
Mónika Göőz United States 24 754 2.0× 121 0.5× 317 1.5× 116 0.8× 83 0.7× 60 1.8k
Mengjun Wang United States 18 402 1.0× 451 2.0× 226 1.1× 87 0.6× 53 0.4× 66 1.3k
Jie Yuan China 22 1.0k 2.7× 394 1.8× 180 0.8× 140 1.0× 52 0.4× 54 1.7k
Natalie Burkard Germany 17 446 1.2× 248 1.1× 156 0.7× 57 0.4× 40 0.3× 28 958
Haihong Zhou China 21 560 1.5× 91 0.4× 182 0.9× 64 0.4× 144 1.2× 44 1.3k

Countries citing papers authored by Tom J. Parry

Since Specialization
Citations

This map shows the geographic impact of Tom J. Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom J. Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom J. Parry more than expected).

Fields of papers citing papers by Tom J. Parry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom J. Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom J. Parry. The network helps show where Tom J. Parry may publish in the future.

Co-authorship network of co-authors of Tom J. Parry

This figure shows the co-authorship network connecting the top 25 collaborators of Tom J. Parry. A scholar is included among the top collaborators of Tom J. Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom J. Parry. Tom J. Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parry, Tom J., Francesco Giganti, Harbir Sidhu, et al.. (2025). Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study). European Radiology. 36(3). 1959–1970. 1 indexed citations
2.
Verdoorn, Todd A., Tom J. Parry, Graziano Pinna, & Jonathan Lifshitz. (2023). Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury. Neurotherapeutics. 20(6). 1603–1615. 6 indexed citations
3.
Dwyer, Mary, Nevin Varghese, Tom J. Parry, et al.. (2023). NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury. Experimental Neurology. 371. 114608–114608. 5 indexed citations
4.
Wang, Jing, Ariana P. Mullin, Anthony O. Caggiano, et al.. (2018). The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination. Brain Research. 1694. 73–86. 17 indexed citations
5.
Parry, Tom J., Anindita Ganguly, J. Luis Guerrero, et al.. (2016). Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction. European Journal of Pharmacology. 796. 76–89. 11 indexed citations
6.
Ganguly, Anindita, et al.. (2016). Recovery of sensorimotor function following sciatic nerve injury across multiple rat strains. Journal of Neuroscience Methods. 275. 25–32. 28 indexed citations
7.
Galindo, Cristi L., Sergey Ryzhov, Yanna Song, et al.. (2014). Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure. Journal of the American Heart Association. 3(5). e000773–e000773. 67 indexed citations
8.
Caggiano, Anthony, Andrew R. Blight, & Tom J. Parry. (2013). Effects of dalfampridine and its metabolites on cloned human potassium channels Kv1.1, Kv1.2, and Kv1.4 expressed in human embryonic kidney cells. PubMed. 2(1). 58–66. 3 indexed citations
9.
Caggiano, Anthony, Andrew R. Blight, & Tom J. Parry. (2013). Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat. PubMed. 2(1). 72–80. 5 indexed citations
10.
Parry, Tom J., Zhihong Huang, Cailin Chen, et al.. (2011). Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis. Blood Coagulation & Fibrinolysis. 22(8). 720–726. 11 indexed citations
11.
Parry, Tom J., et al.. (2011). On the quantitation of an agonist with dual but opposing components of action: Application to vascular endothelial relaxation. European Journal of Pharmacology. 670(1). 204–207. 3 indexed citations
12.
Connelly, Margery A., Tom J. Parry, Edward C. Giardino, et al.. (2010). Torcetrapib Produces Endothelial Dysfunction Independent of Cholesteryl Ester Transfer Protein Inhibition. Journal of Cardiovascular Pharmacology. 55(5). 459–468. 30 indexed citations
13.
Chen, Cailin, Han‐Cheng Zhang, Barbara J. Haertlein, et al.. (2008). Carba‐nucleosides as Potent Antagonists of the Adenosine 5′‐Diphosphate (ADP) Purinergic Receptor (P2Y12) on Human Platelets. ChemMedChem. 3(5). 732–736. 12 indexed citations
14.
Gunnet, Joseph W., Philip J. Rybczynski, Patricia Andrade‐Gordon, et al.. (2008). Pharmacological characterization of RWJ-676070, a dual vasopressin V1A/V2 receptor antagonist. European Journal of Pharmacology. 590(1-3). 333–342. 8 indexed citations
15.
Luci, Diane K., Shyamali Ghosh, Charles E. Smith, et al.. (2007). Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: Synthesis, SAR, and in vivo assessment. Bioorganic & Medicinal Chemistry Letters. 17(23). 6489–6492. 14 indexed citations
16.
Parry, Tom J., et al.. (2006). Effects of drug combinations on smooth muscle cell proliferation: An isobolographic analysis. European Journal of Pharmacology. 532(1-2). 38–43. 7 indexed citations
17.
Parry, Tom J., et al.. (2005). Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries. European Journal of Pharmacology. 524(1-3). 19–29. 93 indexed citations
18.
Huang, Lili, Daniel J. Sexton, Kirsten Skogerson, et al.. (2003). Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2. Journal of Biological Chemistry. 278(18). 15532–15540. 182 indexed citations
19.
Osborn, Blaire L., Les Sekut, Marta L. Corcoran, et al.. (2002). Albutropin: a growth hormone–albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys. European Journal of Pharmacology. 456(1-3). 149–158. 96 indexed citations
20.
Parry, Tom J. & James G. McElligott. (1994). Kainic acid administration in the fastigial nucleus produces differential cardiovascular effects in awake and anesthetized rats. Brain Research. 635(1-2). 27–36. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca Lever Breakdown of academic impact, for papers by Ignacio M. Larráyoz Breakdown of academic impact, for papers by Jaap Rip Breakdown of academic impact, for papers by Mónika Göőz Breakdown of academic impact, for papers by Mengjun Wang Breakdown of academic impact, for papers by Jie Yuan Breakdown of academic impact, for papers by Natalie Burkard Breakdown of academic impact, for papers by Haihong Zhou
Rankless by CCL
2026